Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan Plans Research Zones For Cutting-Edge Medicine R&D

This article was originally published in PharmAsia News

Executive Summary

Japan's government plans to establish research zones around the nation to bring top scientists together on medical research and development efforts. The main focus of the effort, scheduled for completion later this year, is work on stem cells and other cutting-edge medicines. Subsidies and more-relaxed regulations are to be available within each zone that combines university and private industry in advanced medical research. Priority is to be given to biotech pharmaceuticals, induced pluripotent stem cells and regenerative medicine. (Click here for more - a subscription may be required

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068315

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel